Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.
暂无分享,去创建一个
J. Miller | A. Gill | C. Girgis | J. Christie | R. Clifton-Bligh | H. Schneider | J. Serpell | J. Gundara | S. Farrell | R. Carroll | Sunita M C De Sousa | M. Grossmann | S. Harper | S. Ramchand | F. Milat | M. Herath | Julie A. Miller | K. Taubman | S. D. De Sousa | Richard W. Carroll | Justin S. Gundara
[1] L. Rejnmark,et al. Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis , 2021, Osteoporosis International.
[2] R. Eastell,et al. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? , 2020, Postgraduate Medical Journal.
[3] Snehal G. Patel,et al. Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study. , 2020, Surgery.
[4] M. Kurajoh,et al. Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism , 2020, Endocrine.
[5] A. Gill,et al. Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing , 2020, Endocrine Pathology.
[6] S. Wilcox,et al. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort , 2020, Clinical endocrinology.
[7] P. Vestergaard,et al. Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial. , 2020, The lancet. Diabetes & endocrinology.
[8] A. Tabarin,et al. Clinical Characteristics of Familial Hypocalciuric Hypercalcaemia Type 1: A Multicentre Study of 77 Adult Patients. , 2020, Clinical Endocrinology.
[9] A. Mäkitie,et al. Parathyroid cancer: An update. , 2020, Cancer treatment reviews.
[10] R. Eastell,et al. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History , 2020, The Journal of clinical endocrinology and metabolism.
[11] S. Kos,et al. Clinical guidelines and PTH measurement: does assay generation matter? , 2019, Endocrine reviews.
[12] S. Silverberg,et al. Risk factors for vertebral fracture in primary hyperparathyroidism , 2019, Endocrine.
[13] Yu Xia,et al. Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism , 2019, Endocrine.
[14] J. Chabot,et al. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile , 2019, Surgery.
[15] B. Clarke,et al. Asymptomatic Primary Hyperparathyroidism. , 2018, Frontiers of hormone research.
[16] L. Rejnmark,et al. Health‐related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study , 2018, Clinical endocrinology.
[17] A. Chou,et al. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features , 2018, The American journal of surgical pathology.
[18] J. Amado,et al. Bone mineral density evolution and incidence of fractures in a cohort of patients with primary hyperparathyroidism treated with parathyroid surgery vs active surveillance during 6 years of follow-up. , 2019, Endocrinologia, diabetes y nutricion.
[19] H. Schneider,et al. Misclassification of Calcium Status Based on Albumin-Adjusted Calcium: Studies in a Tertiary Hospital Setting. , 2018, Clinical chemistry.
[20] F. Ahmed,et al. The role of ultrasonography in detecting urinary tract calculi compared to CT scan , 2018, Research and reports in urology.
[21] D. Shoback,et al. Familial hypocalciuric hypercalcemia and related disorders. , 2018, Best practice & research. Clinical endocrinology & metabolism.
[22] J. Bilezikian. Primary Hyperparathyroidism , 2018, The Journal of clinical endocrinology and metabolism.
[23] R. Sippel,et al. Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism? , 2018, Clinical medicine insights. Endocrinology and diabetes.
[24] W. Simonds,et al. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. , 2018, Journal of the American College of Surgeons.
[25] S. Silverberg,et al. Primary hyperparathyroidism , 2018, Nature Reviews Endocrinology.
[26] M. Landén,et al. Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management , 2017, World Journal of Surgery.
[27] C. Marcocci,et al. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features , 2017, PloS one.
[28] G. Melnichenko,et al. Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome , 2017, Endocrine connections.
[29] Maryam K. Mohammed,et al. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism , 2017, Surgery.
[30] James X. Wu,et al. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost‐effectiveness analysis incorporating fracture risk reduction , 2017, Surgery.
[31] M. Tublin,et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. , 2016, JAMA surgery.
[32] R. Rizzoli,et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus , 2016, Osteoporosis International.
[33] R. Thakker. Genetics of parathyroid tumours , 2016, Journal of internal medicine.
[34] L. Gianotti,et al. Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria. , 2016, The Journal of clinical endocrinology and metabolism.
[35] Ning Li,et al. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism , 2016, Annals of Internal Medicine.
[36] C. Marcocci,et al. Primary hyperparathyroidism , 2016, Nature Reviews Disease Primers.
[37] M. Pawłowska,et al. An overview of normocalcemic primary hyperparathyroidism , 2015, Current opinion in endocrinology, diabetes, and obesity.
[38] M. Prasad,et al. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. , 2015, Journal of the American College of Surgeons.
[39] K. Kos,et al. Parathyroid Hormone, Cognitive Function and Dementia: A Systematic Review , 2015, PloS one.
[40] Y. Toledano,et al. Pregnancy outcomes in women with primary hyperparathyroidism. , 2015, The Journal of clinical endocrinology and metabolism.
[41] J. Bilezikian,et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. , 2015, The Journal of clinical endocrinology and metabolism.
[42] J. Nordenström,et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. , 2015, The Journal of clinical endocrinology and metabolism.
[43] W. Simonds,et al. Hyperparathyroidism-jaw tumor syndrome: Results of operative management. , 2014, Surgery.
[44] A. Jiménez-García,et al. Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study. , 2014, Surgery.
[45] C. Marcocci,et al. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. , 2014, The Journal of clinical endocrinology and metabolism.
[46] L. Rejnmark,et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.
[47] Q. Duh,et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.
[48] E. Hagström,et al. Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts. , 2014, The Journal of clinical endocrinology and metabolism.
[49] J. Bilezikian,et al. Bone disease in primary hyperparathyroidism. , 2014, Arquivos brasileiros de endocrinologia e metabologia.
[50] Collin J. Weber,et al. Predictors of Bone Mineral Density Improvement in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism , 2014, World Journal of Surgery.
[51] A. Gill. Understanding the Genetic Basis of Parathyroid Carcinoma , 2014, Endocrine Pathology.
[52] R. Eastell,et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.
[53] R. Eastell,et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.
[54] David F. Schneider,et al. Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism. , 2013, Surgery.
[55] S. Zouwail,et al. Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism. , 2013, Annals of the Royal College of Surgeons of England.
[56] D. Borderie,et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.
[57] X. Badia,et al. Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism , 2013, Health and Quality of Life Outcomes.
[58] S. Wiseman,et al. Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior? , 2013, American journal of surgery.
[59] A. Adams,et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. , 2013, The Journal of clinical endocrinology and metabolism.
[60] P. Chanson,et al. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.
[61] Herb Chen,et al. What is the utility of distal forearm DXA in primary hyperparathyroidism? , 2012, The oncologist.
[62] R. Lifton,et al. Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism , 2012, Hormones and Cancer.
[63] M. Pearle,et al. Defining hypercalciuria in nephrolithiasis. , 2011, Kidney International.
[64] P. Vestergaard,et al. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. , 2011, The Journal of clinical endocrinology and metabolism.
[65] M. Cooper,et al. Review: New perspectives in the management of primary hyperparathyroidism , 2010, Therapeutic advances in endocrinology and metabolism.
[66] K. Foley,et al. Urine Calcium: Laboratory Measurement and Clinical Utility , 2010 .
[67] E. Hauge,et al. Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case‐control study using HR‐pQCT , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[68] J. Pasieka,et al. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. , 2009, Surgery.
[69] J. Miller,et al. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] C. Marcocci,et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. , 2009, The Journal of clinical endocrinology and metabolism.
[71] R. Lazar,et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. , 2009, The Journal of clinical endocrinology and metabolism.
[72] Martha A Zeiger,et al. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. , 2008, Surgery.
[73] S. Challinor,et al. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. , 2008, Surgery.
[74] E. Siris,et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. , 2008, The Journal of clinical endocrinology and metabolism.
[75] G. Curhan,et al. 24-h uric acid excretion and the risk of kidney stones. , 2008, Kidney international.
[76] H. Teede,et al. Fracture prevention strategies in patients presenting to Australian hospitals with minimal‐trauma fractures: a major treatment gap , 2007, Internal medicine journal.
[77] B. Skogseid,et al. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. , 2007, The Journal of clinical endocrinology and metabolism.
[78] M. Rubin,et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. , 2007, The Journal of clinical endocrinology and metabolism.
[79] C. Marcocci,et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. , 2007, The Journal of clinical endocrinology and metabolism.
[80] A. Gill,et al. Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.
[81] Lindi H Vanderwalde,et al. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. , 2006, Archives of surgery.
[82] J. Rastad,et al. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. , 2006, European journal of endocrinology.
[83] Martin Coulombe,et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. , 2006, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[84] G. Divine,et al. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. , 2004, The Journal of clinical endocrinology and metabolism.
[85] Jeffrey E. Lee,et al. Parathyroid carcinoma: A 22‐year experience , 2004, Head & neck.
[86] R. Dickerson,et al. Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[87] P. Vestergaard,et al. Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study , 2004, Journal of internal medicine.
[88] J. Carpten,et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.
[89] P. Vestergaard,et al. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism , 2003, BMJ : British Medical Journal.
[90] S. Silverberg,et al. Age as a criterion for surgery in primary hyperparathyroidism. , 2002, The American journal of medicine.
[91] J. Rastad,et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. , 2002, The Journal of clinical endocrinology and metabolism.
[92] P. Vestergaard,et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study , 2002, BMJ : British Medical Journal.
[93] J. Ryan,et al. Surgical treatment of hyperparathyroidism improves health-related quality of life. , 2002, Archives of surgery.
[94] J. Rastad,et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. , 2000, The Journal of clinical endocrinology and metabolism.
[95] W. O'Fallon,et al. Primary Hyperparathyroidism and the Risk of Fracture: A Population‐Based Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[96] I. Fleming,et al. Two hundred eighty‐six cases of parathyroid carcinoma treated in the U.S. between 1985–1995 , 1999, Cancer.
[97] J. Carney,et al. Parathyroid Carcinoma: Clinical and Pathologic Features in 43 Patients , 1992, Medicine.
[98] J. Knol,et al. Malignancy and concomitant primary hyperparathyroidism , 1988, Journal of surgical oncology.
[99] J. Rydberg,et al. Hyperparathyroidism in the Elderly , 1983, Annals of surgery.
[100] G. Mundy,et al. PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATION , 1980, The Lancet.
[101] J. V. van Heerden,et al. Cancer of the parathyroid glands. , 1979, Archives of surgery.
[102] B. Castleman,et al. Parathyroid carcinoma. A study of 70 cases , 1973, Cancer.